A randomized, cross-over comparison of preference between two reusable insulin pen devices in pen-naïve adults with diabetes

References

• Brunton S. Insulin delivery systems: reducing barriers to insulin therapy and advancing diabetes mellitus treatment. Am J Med 2008;121:S35-41
   PubMed Web of Science ®Google Scholar
• Peyrot M, Rubin RR, Khunti K. Addressing barriers to initiation of insulin in patients with type 2 diabetes. Prim Care Diabetes 2010;4(Suppl 1):S11-18
   PubMedGoogle Scholar
• Polonsky WH, Hajos TR, Dain MP, et al. Are patients with type 2 diabetes reluctant to start insulin therapy? An examination of the scope and underpinnings of psychological insulin resistance in a large, international population. Curr Med Res Opin 2011;27:1169-74
   PubMed Web of Science ®Google Scholar
• Spollett G. Insulin devices: addressing barriers to insulin therapy with the ideal pen. Diabetes Educ 2008;34:957-67
   PubMed Web of Science ®Google Scholar
• Asakura T, Seino H, Nakano R, et al. A comparison of the handling and accuracy of syringe and vial versus prefilled insulin pen (FlexPen). Diabetes Technol Ther 2009;11:657-61
   PubMed Web of Science ®Google Scholar
• Graff MR, McClanahan MA. Assessment by patients with diabetes mellitus of two insulin pen delivery systems versus a vial and syringe. Clin Ther 1998;20:486-96
   PubMed Web of Science ®Google Scholar
• Kadiri A, Chraibi A, Marouan F, et al. Comparison of NovoPen 3 and syringes/vials in the acceptance of insulin therapy in NIDDM patients with secondary failure to oral hypoglycaemic agents. Diabetes Res Clin Pract 1998;41:15-23
   PubMed Web of Science ®Google Scholar
• Korytkowski M, Bell D, Jacobsen C, et al. A multicenter, randomized, open-label, comparative, two-period crossover trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial/syringe for insulin injection in patients with type 1 or 2 diabetes mellitus. Clin Ther 2003;25:2836-48
   PubMed Web of Science ®Google Scholar
• Molife C, Lee LJ, Shi L, et al. Assessment of patient-reported outcomes of insulin pen devices versus conventional vial and syringe. Diabetes Technol Ther 2009;11:529-38
   PubMed Web of Science ®Google Scholar
• Rubin RR, Peyrot M. Quality of life, treatment satisfaction, and treatment preference associated with use of a pen device delivering a premixed 70/30 insulin aspart suspension (aspart protamine suspension/soluble aspart) versus alternative treatment strategies. Diabetes Care 2004;27:2495-7
   PubMed Web of Science ®Google Scholar
• Rubin RR, Peyrot M. Factors affecting use of insulin pens by patients with type 2 diabetes. Diabetes Care 2008;31:430-2
   PubMed Web of Science ®Google Scholar
• Summers KH, Szeinbach SL, Lenox SM. Preference for insulin delivery systems among current insulin users and nonusers. Clin Ther 2004;26:1498-505
   PubMed Web of Science ®Google Scholar
• Korytkowski M, Niskanen L, Asakura T. FlexPen: addressing issues of confidence and convenience in insulin delivery. Clin Ther 2005;27(Suppl B):S89-100
   PubMed Web of Science ®Google Scholar
• Magnotti MA, Rayfield EJ. An update on insulin injection devices. Insulin 2007;2:173-81
   Google Scholar
• Donsmark M, Herold L, Kristensen CM. A comparison of injection force and dosage scale size between NovoPen 3 and NovoPen 4. Diabetes Technol Ther 2009;11:581-5
   PubMed Web of Science ®Google Scholar
• Israel-Bultman H, Hyllested-Winge J, Kolaczynski M, et al. Comparison of preference for NovoPen((R)) 4 with previous insulin pen treatments after 12 weeks in adult patients with type 1 and type 2 diabetes: a multicenter observational study. Clin Ther 2011;33:346-57
   PubMed Web of Science ®Google Scholar
• Selam JL. Evolution of diabetes insulin delivery devices. J Diabetes Sci Technol 2010;4:505-13
   PubMedGoogle Scholar
• Perfetti R. Reusable and disposable insulin pens for the treatment of diabetes: understanding the global differences in user preference and an evaluation of inpatient insulin pen use. Diabetes Technol Ther 2010;12(Suppl 1):S79-85
   PubMed Web of Science ®Google Scholar
• Reimer T, Hohberg C, Pfutzner AH, et al. Intuitiveness, instruction time, and patient acceptance of a prefilled insulin delivery device and a reusable insulin delivery device in a randomized, open-label, crossover handling study in patients with type 2 diabetes. Clin Ther 2008;30:2252-62
   PubMed Web of Science ®Google Scholar
• Friedrichs A, Basso N, Adler S. Dose accuracy of the ClikSTAR, NovoPen 4, and Luxura insulin pens: results of laboratory and field studies. J Diabetes Sci Technol 2011;5:1179-84
   PubMedGoogle Scholar
• Davis TC, Long SW, Jackson RH, et al. Rapid estimate of adult literacy in medicine: a shortened screening instrument. Fam Med 1993;25:391-5
   PubMedGoogle Scholar
• Clark PE, Valentine V, Bodie JN, et al. Ease of use and patient preference injection simulation study comparing two prefilled insulin pens. Curr Med Res Opin 2010;26:1745-53
   PubMed Web of Science ®Google Scholar
• Ignaut DA, Schwartz SL, Sarwat S, et al. Comparative device assessments: Humalog KwikPen compared with vial and syringe and FlexPen. Diabetes Educ 2009;35:789-98
   PubMed Web of Science ®Google Scholar
• Pen-injectors for medical use – Part 1: pen-injectors – requirements and test methods. ISO 11608-1:2000(E).International Organization for Standardization. Available at: http://www.iso.org/iso/catalogue_detail.htm?csnumber=19545 [Last accessed 11 June 2012]
   Google Scholar
• Fu H, Qu Y, Zhu B, Huster W. A Bayesian approach to the statistical analysis of device preference studies. Pharm Stat 2012;11:149-56
   PubMed Web of Science ®Google Scholar
• Guo X, Sommavilla B, Vanterpool G, et al. Evaluation of a new durable insulin pen with memory function among people with diabetes and healthcare professionals. Expert Opin Drug Deliv 2012;9:355-6
   PubMed Web of Science ®Google Scholar
• Marcus A. Diabetes care – insulin delivery in a changing world. Medscape J Med 2008;10:120
   PubMedGoogle Scholar
• Food and Drug Administration. Guidance for the Use of Bayesian Statistics in Medical Device Clinical Trials. 2010. http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/ucm071072.htm Accessed 01 Mar 2013
   Google Scholar